Our 14th annual Japan-U.S. Innovation Awards Symposium will be held at Stanford University on Thursday, July 18th! For those who have a Stanford ID, register for free! Visit https://lnkd.in/geyrFhz for details.
Innovation Awards Showcase Companies Announced! 2024 Japan-U.S. Innovation Awards Symposium next month! AI Medical Service Inc. Citadel AI EdgeCortix Helical Fusion Synspective Inc. Read more about this year's Showcase companies here: https://lnkd.in/gB2a4Z6y
Strategist | CMO | Author | Speaker | Transformation | Innovation | Technology, Telecoms, Banking, Financial Services, Media and Entertainment, Consumer Goods, Healthcare and Life Sciences
The second in our new series of micro-clips that deliver fresh insights and learnings for innovators in life sciences and healthcare: “Snapshots From The Edge”.
Watch David Pardoe, SVP and Head of Global Molecular Architects at Evotec, lay out the stark challenges in drug discovery and the urgent role AI must play. "?????? ???? ?????? ???????? ???????? ???? ???? ???????? ???????????????????? … ???? ?????????????? ?????? ???? ???????? ?????????????????????? ?????? ???????? - ?????????????? ???????????????????????? - ???? ?????? ???? ???????? ?? ???????? ???????? ???? ?????? ???????????? ?????????????? ?????? ??????????????, ?????? ???? ???????? ???? ???????? ?????????? ???????????? ?????????????????? ?????????????????? ???? ???????? ?????????????????? ?????? ??????????????????????." ?? Stay Updated! ------------------- ? Webinar invites ? Industry updates ? Access to exclusive GT LifeScience reports -------------------- ?? Sign Up at https://lnkd.in/e8w4bYn8 #DrugDiscovery #AI #LifeScience #Innovation #Webinar #SnapshotsFromTheEdge
From Lab to Life: AI's Role in Drug Discovery and Personalized Medicine https://bit.ly/3UpKgJ2
Envisagenics' co-founder & CTO,?Martin Akerman, will be participating in?BioTechX Europe?next week. He will be speaking on the panel,?AI in Drug Development: From Breakthroughs to Breakdowns, on October 9th at 5:25 PM. The panel will explore how artificial intelligence is transforming drug discovery and development, as well as the challenges and opportunities ahead. #BioTechXEurope #AIinDrugDevelopment #HealthcareInnovation #SpliceCore #Envisagenics #AI
Montai CSO Lamya Shihabuddin is chairing the #PDDPSummit today in?Boston. Together with leaders from across the drug?discovery landscape, Lamya is sharing insights on?how Montai is leveraging AI to create more precision and predictability in early #drugdiscovery.?
?? Don't miss out on our latest #trainingprogram #AI is transforming the #Biopharma industry, and you can be at the forefront of this revolution ! Join us to explore the integration of AI in Biopharma & Medtech. Discover how relevant data models, AI technologies and combinatorial optimization are reshaping operations & manufacturing. Gain insights from successful case studies & prepare to tackle industry challenges head-on ! Register now ?? https://lnkd.in/ehGUqmSC Avec DNAlytics Rombio Université catholique de Louvain #BuildingTheFutureOfBiotech #AI #MachineLearning #Innovation #scheduling #optimization
AI for target discovery: the start of a long road. In the fifth and final article in BioCentury's Back to School 2024, Editor in Chief Simone Fishburn and colleague write that investments in AI in drug discovery are picking up, as the picture starts to form of how target discovery may benefit
From our unique database of 70 million sequences, MAbSilico finds alternative sequences to replace any antibody through computational design. Find out how we're taking antibody discovery to the next level: ?? mabsilico.com #Antibody #AI #ML #DrugDesign #DrugDiscovery
A short Video : Check, How Deloitte Atlas AI, powered by NVIDIA(BioNeMo) accelerate drug discovery by rapidly generating 3D biomolecular structures and predicting drug-to-protein binding. https://lnkd.in/gEnyiRDD #speedoptimization #drugdiscovery
Presidents Club Winner, 3X Rep of the Year — Medical Device Sales Rep- Spinal Cord Stimulation and SI Joint Fusion— Active Secret Security Clearance— Aircraft Maintenance Officer
Listen to Dr Usman Latif discuss our new AdaptivAI launch!
Welcome to the relentless pursuit of optimal relief. Last week, we announced the launch of our groundbreaking HFX AdaptivAI? powering HFX iQ?, and we're already seeing exciting results. Congratulations to Dr. Usman Latif for the first commercial use of HFX AdaptivAI technology, demonstrating the rapid impact of our innovation on patients' lives. Dr. Latif is instrumental in assisting Nevro in bringing this life-changing technology to patients. His dedication aligns with our vision of freeing patients from the burden of chronic pain. To hear more about his experience with HFX AdaptivAI please visit: https://lnkd.in/ggpbu2ph For additional safety information, please visit: https://lnkd.in/gVcSW7r2 #HFXAdaptivAI #HFXiQ #SpinalCordStimulation #ArtificialIntelligence #AI #ChronicPain #PainRelief
